Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy

References

Page 1

	Year	Citations
A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy Jeffery D. Molkentin, Jianrong Lu, Christopher L. Antos, Cell Cardiac MuscleTranscriptional RegulationCardiomyopathyMolecular PhysiologySignal Transduction	1998	2.6K
Oral Sildenafil in the Treatment of Erectile Dysfunction Irwin Goldstein, Tom F. Lue, Harin Padma-Nathan, New England Journal of Medicine	1998	2.1K
Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore Magdalena Juhaszova, Dmitry B. Zorov, Suhn-Hee Kim, Journal of Clinical Investigation	2004	988
The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice Orlando F. Bueno The EMBO Journal Cardiac MuscleCardiomyopathyHeart FailureSignal TransductionMolecular Physiology	2000	782
Calcineurin/NFAT Coupling Participates in Pathological, but not Physiological, Cardiac Hypertrophy Benjamin J. Wilkins, Yan‐Shan Dai, Orlando F. Bueno, Circulation Research	2003	756
Regulation of Myocardial Contractility and Cell Size by Distinct PI3K-PTEN Signaling Pathways Michael A. Crackower, Gavin Y. Oudit, I. Kozieradzki, Cell MechanobiologyCardiac MuscleCardiomyopathyCell SizeMolecular Physiology	2002	578
Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A Paula M. Oliver, Jennifer E. Fox, Howard A. Rockman, Proceedings of the National Academy of Sciences HypertensionHeart FailureImmunologySudden DeathCardiovascular Function	1997	564
Oral sildenafil in the treatment of erectile dysfunction Irwin Goldstein, Tom F. Lue, Harin Padma-Nathan, The Journal of Urology Erectile DysfunctionNeuromodulation TherapiesPharmacotherapyExperimental PharmacologySocial Sciences	2002	498
Clinical efficacy of sildenafil in primary pulmonary hypertension B.K.S. Sastry, C Narasimhan, N. Krishna Reddy, Journal of the American College of Cardiology HypertensionPulmonary Arterial HypertensionPrimary Pulmonary HypertensionCardiovascular DiseasePulmonary Pharmacology	2004	489
Activated glycogen synthase-3β suppresses cardiac hypertrophy <i>in vivo</i> Christopher L. Antos, Timothy A. McKinsey, Norbert Frey, Proceedings of the National Academy of Sciences	2002	476

Page 1